Three under-the-radar small-cap stocks made outsized moves on Wednesday, each driven by a distinct catalyst that highlights how quickly thinly traded shares can reprice. Lyell Immunopharma jumped 43% after announcing an $80 million share sale, Helen of Troy climbed 22% after rejecting a $37-per-share takeover approach, and LivaNova rose 24% after beating earnings estimates and raising its 2026 guidance.
For everyday investors, these moves are a reminder that small-cap stocks—companies with relatively small market values—can be far more volatile than their larger peers. Because fewer shares change hands on a typical day, a single piece of news can cause outsized price swings.
Lyell's cash infusion
Lyell Immunopharma, a clinical-stage biotech focused on cell therapies for cancer, said it would sell $80 million of stock to a group of investors including ARCH Venture Partners and Adage Capital Management. The company said the proceeds extend its funding runway into 2028, giving it more time to advance its pipeline without needing to raise capital soon.
The stock's 43% surge came on volume of roughly 925,000 shares, compared with an average of about 150,000. That six-fold jump in trading activity is a classic sign of a catalyst-driven repricing. However, the share sale also adds new supply to the market, which can weigh on the stock in the weeks ahead as those new shares are absorbed.
Helen of Troy rejects a bid
Helen of Troy, the consumer products company behind brands like OXO and Hydro Flask, said it turned down an unsolicited, non-binding $37-per-share cash proposal from Empower Brands, a portfolio company owned by Spectrum Brands and Oaktree Capital Management. The company's board determined the offer undervalued the business, and the stock rose 22% on volume of about 1.7 million shares, versus roughly 436,000 typically.
Rejecting a bid doesn't mean the story is over. In many cases, the suitor may come back with a higher offer, or other parties could step in. But it also signals that management believes the company is worth more than the market was pricing in. For investors, the jump reflects both the possibility of a future deal and the market's reassessment of the company's standalone value.
LivaNova's guidance boost
LivaNova, a medical-device maker focused on cardiac surgery and neuromodulation, beat expectations on adjusted profit and revenue for its latest quarter and raised its 2026 guidance. The company's shares rose 24% on volume of about 2.3 million, compared with a typical 640,000.
An earnings beat combined with a raised outlook is a powerful signal for any company, but especially for a small cap where analyst coverage may be limited. The guidance increase suggests management sees durable momentum, which can reset longer-term expectations and attract new investors.
What it means for investors
These three moves illustrate a key dynamic in small-cap investing: liquidity. When a stock normally trades only a few hundred thousand shares a day, a burst of event-driven orders can quickly exhaust the available supply. That can widen the bid-ask spread—the gap between the highest price a buyer will pay and the lowest price a seller will accept—and force the price to jump to the next available level.
As a result, the headline percentage move can overstate the fundamental change. After the initial flurry fades, prices often settle closer to what the news actually implies. For Lyell, the cash runway extension is positive, but the new shares could cap upside. For Helen of Troy, the rejection leaves uncertainty about whether a higher bid will come. For LivaNova, the guidance raise is the most concrete signal of improved fundamentals.
For everyday investors, the takeaway is to be cautious when chasing sharp moves in thinly traded stocks. The price you see on your screen may not reflect the price you can actually get, and volatility can cut both ways. If you own these names, it's worth understanding the specific catalyst and how it changes the company's outlook—not just the day's percentage gain.
These moves come amid a broader market backdrop where stocks have rallied on election clarity, and healthcare stocks have seen mixed reactions to corporate news. Small caps, in particular, can be sensitive to shifts in the economic and policy outlook, as they often have less financial flexibility than larger companies.
Investors should also keep an eye on shifting options demand, which can affect how these stocks trade. And with oil prices sliding, the broader market's direction remains uncertain.
In short, these three small caps show how a single piece of news can dramatically change a stock's price—and why it's important to look beyond the headline move to understand what really changed.
